Get my own profile
Public access
View all28 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Tom GauntMRC Integrative Epidemiology Unit, University of BristolVerified email at bristol.ac.uk
- Santiago RodriguezSenior Lecturer in Population and Molecular Genetics, University of BristolVerified email at bristol.ac.uk
- Philip C HaycockVerified email at bristol.ac.uk
- David EvansProfessor of Statistical Genetics, University of QueenslandVerified email at uq.edu.au
- Nazrul IslamAssociate Professor, University of SouthamptonVerified email at mail.harvard.edu
- Claudia LangenbergBerlin Institute of Health at Charité, Germany & MRC Epidemiology Unit, University of Cambridge, UKVerified email at charite.de
- Laura WittemansSir Henry Wellcome Fellow, University of OxfordVerified email at wrh.ox.ac.uk
- Louise V WainUniversity of LeicesterVerified email at leicester.ac.uk
- John P. KempUniversity of Queensland and University of BristolVerified email at bristol.ac.uk
- Martin D TobinUniversity of LeicesterVerified email at leicester.ac.uk
- Nick ShrineUniversity of LeicesterVerified email at leicester.ac.uk
- Denis A BairdBiogenVerified email at bristol.ac.uk
- Boris NoyvertUniversity of BirminghamVerified email at bham.ac.uk
- Tom G RichardsonGlaxoSmithKlineVerified email at gsk.com
- Nicholas BowkerPhD student University of CambridgeVerified email at mrc-epid.cam.ac.uk
- Chiara BatiniUniversity of LeicesterVerified email at le.ac.uk
- Maik PietznerGroup leader at BIH (Charité Berlin) and Professor PHURI (@QMUL)Verified email at bih-charite.de
- Lea Trela-LarsenNational Centre for Pharmacoeconomics IrelandVerified email at tcd.ie
- Nicholas John TimpsonUniversity of BristolVerified email at bristol.ac.uk
- Johann de JongUCBVerified email at ucb.com
Follow
A. Mesut Erzurumluoglu
Senior Scientist & PO, Boehringer Ingelheim. Previously at Univ. of Cambridge, Leicester & Bristol
Verified email at boehringer-ingelheim.com - Homepage